|
- Lung Cancer - Medscape
Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
- Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
Dr Kris reviews the latest treatment advances in small cell lung cancer, including new standards of care and emerging therapies in 2024
- Solution to A Forgetful Lung Cancer Patient With Hyponatremia - Medscape
A 70-year-old man with non-small-cell lung cancer presented to the clinic with fatigue and dizziness for 1 month He complained of weight loss (5-10 pounds) and anorexia, and his wife said he
- Toxicity Linked to Longer Survival in Patients With NSCLC
Patients who have immune-related adverse events when treated for non–small cell lung cancer (NSCLC) may live longer than those without these complications, according to a new study
- FDA Approves Tarlatamab for Extensive-Stage SCLC - Medscape
The US Food and Drug Administration has granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen) for extensive-stage small cell lung cancer (SCLC) with disease progression on or after
- Fine Particulate Matter Affects EGFR-Mutated Lung Cancers
Through an epidemiological analysis, the study establishes a dose-dependent association between PM 2 5 exposure and the estimated incidence of EGFR -mutated non–small cell lung cancers
- Skin Care Regimen Cuts Toxicities of Combo NSCLC Therapy
A preventative and proactive dermatologic regimen reduces skin and nail adverse reactions in patients with EGFR-mutant NSCLC receiving first-line treatment with amivantamab plus lazertinib
- Spinal Cord Compression - Medscape
Some tumors, such as Hodgkin's lymphoma and small cell lung cancer, are very sensitive to chemotherapeutic agents, whereas lymphoma and myeloma are more radiosensitive, and breast and prostate
|
|
|